loxicodegol (NKTR-181) - Nektar Therapeutics
Nektar Therapeutics: Jefferies London Healthcare Conference 2016 (Nektar Therapeutics, Jefferies 2016 London Healthcare Conference) - Nov 19, 2016 - Anticipated initiation of P3 pivotal human abuse liability trial in pain in Q4 2016; Anticipated top-line data from P3 trial in pain in H1 2017 
Anticipated new P3 trial • Anticipated P3 data: top line Demo Pain • Pain
http://wsw.com/webcast/jeff100/nktr/
 
Nov 19, 2016
 
 
20115062-b228-4fbb-a074-f5ecba494506.jpg